SGS 742

Drug Profile

SGS 742

Alternative Names: CGP-36742; DVD-742; Lu-AE58479; SGS-742

Latest Information Update: 29 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novartis
  • Developer Lundbeck A/S; Novartis
  • Class Antidementias; Antiepileptic drugs; Nootropics; Organophosphorus compounds
  • Mechanism of Action GABA B receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Alzheimer's disease; Attention-deficit hyperactivity disorder; Epilepsy; Mild cognitive impairment

Most Recent Events

  • 13 Dec 2005 Data presented at the 35th Annual Meeting of the Society of Neuroscience (SfN-2005) have been added to the Alzheimer's Disease pharmacodynamics section
  • 22 Mar 2005 Phase-II clinical trials in Attention-deficit hyperactivity disorder in USA (PO)
  • 10 May 2004 Data presented at the 56th Annual Meeting of the American Academy of Neurology (AAN-2004) have been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top